By Nick Paul Taylor
Zosano Pharma has run out of road. After working to find a strategic alternative in the wake of the FDA’s refusal to review its submission, the transdermal drug delivery specialist has now filed for paperwork for Chapter 11 bankruptcy.
read more
By Nick Paul Taylor
Arcutis Biotherapeutics has delivered a phase 3 win for its roflumilast foam formulation. With the cream version already under review at the FDA in plaque psoriasis, the topical drug delivery specialist has now gathered up the data to support a filing for the foam variant in seborrheic dermatitis.
read more
By Nick Paul Taylor
Zylö Therapeutics has secured funding to advance its Z-pod topical delivery particles, putting together a $5.2 million series B round to support work on a technology with applications in erectile dysfunction and cutaneous lupus.
read more
By Conor Hale,Heather Landi
Fierce Healthcare and Fierce Medtech compiled a list highlighting some of the biggest rising stars in the health tech industry, spanning the fields of artificial intelligence, software development and health IT.
read more
By Teresa Carey
This week on "The Top Line," we discuss our special report on the top 20 drugs by 2021 sales, and it is no surprise that products that fight COVID-19 dominated the biopharma landscape. We also talk about this weekend’s ASCO meeting and the week's other big headlines. Plus, we have bloopers!
read more
Sponsored by: PwC
Don’t miss these critical considerations when evaluating your HCP interactions management program.
Sponsored by: Merit Solutions
Quality operations guide your organization through regulatory compliance processes and safeguard your products, processes, and reputation. But your team is capable of so much more. Quality incident data and processes can be a driver of significant business value if shared with other stakeholders.
Sponsored by: Blue Matter, strategic consultants in the life sciences
Recent trends are driving big changes in Medical Affairs. This paper explores why, and what MA teams can do to stay ahead of the curve.
Sponsored by: Catalent
Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays?
Sponsored by: Catalent
Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities
Sponsored by: Catalent
What are key considerations for intranasal delivery in the treatment of acute and chronic conditions?
